New CHA2DS2-VASc-HSF score predicts the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction

[1] Levine GN(2016)2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction J Am Coll Cardiol 67 1235-1250

[2] Bates ER(2019)The elevated soluble ST2 predicts no-reflow phenomenon in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention J Atheroscler Thromb 26 970-978

[3] Blankenship JC(2019)Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Heart Vessel 34 1600-1607

[4] Bailey SR(2015)The no-reflow phenomenon: state of the art Arch Cardiovasc Dis 108 661-674

[5] Bittl JA(2018)Advances in coronary no-reflow phenomenon-a contemporary review Curr Atheroscler Rep 20 44-272

[6] Cercek B(2010)Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest. 137 263-513

[7] Somuncu MU(2014)The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation Atherosclerosis. 237 504-138

[8] Akgun T(2017)CHA2DS2-VASc score predicts in-hospital and long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who were undergoing primary percutaneous coronary intervention Clin Appl Thromb Hemost 23 132-886

[9] Cakir MO(2018)Predictive value of CHA2DS2-VASc score for ischemic events in patients undergoing percutaneous coronary intervention Angiology. 70 878-398

[10] Akgul F(2018)CHA2DS2-VASc and R2-CHA2DS2-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction Postepy Kardiol Interwencyjnej 14 391-825

[1] Levine GN(2016)2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction J Am Coll Cardiol 67 1235-1250

[2] Bates ER(2019)The elevated soluble ST2 predicts no-reflow phenomenon in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention J Atheroscler Thromb 26 970-978

[3] Blankenship JC(2019)Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Heart Vessel 34 1600-1607

[4] Bailey SR(2015)The no-reflow phenomenon: state of the art Arch Cardiovasc Dis 108 661-674

[5] Bittl JA(2018)Advances in coronary no-reflow phenomenon-a contemporary review Curr Atheroscler Rep 20 44-272

[6] Cercek B(2010)Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest. 137 263-513

[7] Somuncu MU(2014)The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation Atherosclerosis. 237 504-138

[8] Akgun T(2017)CHA2DS2-VASc score predicts in-hospital and long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who were undergoing primary percutaneous coronary intervention Clin Appl Thromb Hemost 23 132-886

[9] Cakir MO(2018)Predictive value of CHA2DS2-VASc score for ischemic events in patients undergoing percutaneous coronary intervention Angiology. 70 878-398

[10] Akgul F(2018)CHA2DS2-VASc and R2-CHA2DS2-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction Postepy Kardiol Interwencyjnej 14 391-825